Eculizumab and recurrent C3 glomerulonephritis

被引：0
|
作者：
Sevgi Gurkan
Billie Fyfe
Lynne Weiss
Xue Xiao
Yuzhou Zhang
Richard J. Smith
机构：
[1] UMDNJ-Robert Wood Johnson Medical School,Department of Pediatrics, Division of Pediatric Nephrology
[2] UMDNJ-Robert Wood Johnson Medical School,Department of Pathology
[3] University of Iowa,Department of Medicine, Division of Nephrology and Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine
[4] Robert Wood Johnson Medical School,Department of Pediatrics, Division of Pediatric Nephrology
[5] University of Medicine and Dentistry of New Jersey,undefined
来源：
Pediatric Nephrology | 2013年 / 28卷
关键词：
Eculizumab; C3 Glomerulonephritis; Renal transplant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1975 / 1981
页数：6
相关论文
共 50 条
  • [31] C3 Glomerulonephritis Triggered by Toxocariasis
    Ben M'rad, Mona
    Beaulac, Alexandre
    Palanchuck, Steven
    Beaunoyer, Veronique
    Me Linh Luong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 788 - 788
  • [32] C3 DOMINANT MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AS UNUSUAL PRESENTATIONS OF C3 GLOMERULOPATHY
    Hanna, Ramy
    Selamet, Umut
    Arman, Farid
    Wilson, James M.
    Kurtz, Ira
    Yabu, Julie
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 581 - 581
  • [33] A case report of recurrent C3 glomerulonephritis 18 months after renal transplantation
    Kakita H.
    Miyake T.
    Komiya T.
    Tsukamoto T.
    Muso E.
    Renal Replacement Therapy, 2 (1)
  • [34] A CASE REPORT OF RECURRENT C3 GLOMERULONEPHRITIS POST-COVID INFECTION AND VACCINATION
    Reddy, Indraneel
    Anand, Manish
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S121 - S121
  • [35] Eculizumab (Anti-C5) for Treatment of Severe Antibody-Mediated Rejection (ABMR) and Recurrent C3 Glomerulonephritis in Renal Allografts: A Single Center Experience.
    Jordan, S.
    Choi, J.
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Najjar, R.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 329 - 329
  • [36] Eculizumab for Treatment of Rapidly Progressive C3 Glomerulopathy
    Le Quintrec, Moglie
    Lionet, Arnaud
    Kandel, Christine
    Bourdon, Franck
    Gnemmi, Viviane
    Colombat, Magali
    Goujon, Jean-Michel
    Fremeaux-Bacchi, Veronique
    Fakhouri, Fadi
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (03) : 484 - 489
  • [37] C3 glomerulonephritis: a new category of glomerulonephritis with etiopathogenic implications
    Taborda Murillo, Alejandra
    Arroyave Suarez, Mariam Jose
    Fernando Arias, Luis
    IATREIA, 2015, 28 (01) : 24 - 34
  • [38] Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft
    Moog, Philipp
    Jost, Philipp J.
    Buettner-Herold, Maike
    BMC NEPHROLOGY, 2018, 19
  • [39] Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft
    Philipp Moog
    Philipp J. Jost
    Maike Büttner-Herold
    BMC Nephrology, 19
  • [40] A case of recurrent proliferative glomerulonephritis with monoclonal IgG deposits or de novo C3 glomerulonephritis after kidney transplantation
    Tamura, Tomomi
    Unagami, Kohei
    Okumi, Masayoshi
    Kakuta, Yoichi
    Horita, Shigeru
    Ishida, Hideki
    Koike, Junki
    Honda, Kazuho
    Tanabe, Kazunari
    Nitta, Kosaku
    NEPHROLOGY, 2018, 23 : 76 - 80
12345